awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28077955-D35BDB0C-01EF-4C76-9EE4-B784768B56E6
Q28077955-D35BDB0C-01EF-4C76-9EE4-B784768B56E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077955-D35BDB0C-01EF-4C76-9EE4-B784768B56E6
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets
P2860
Q28077955-D35BDB0C-01EF-4C76-9EE4-B784768B56E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077955-D35BDB0C-01EF-4C76-9EE4-B784768B56E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b615c752cd3bd56361d3e1ee5b62471744cdcf34
P2860
Inhibiting the C5-C5a receptor axis.